pharmatlas:templates:drug_page []

This page is read only. You can view the source, but not change it. Ask your administrator if you think this is wrong.
<WRAP right 280px>
<WRAP infobox>
{{:images:drugs:drug_name_structure.png?220|Drug Name (chemical structure)}}

^ Drug Name |
| Brand Names | Brand1®, Brand2® |
| Drug Class | [[namespace:class:start|Class Name]] |
| Subclass | [[namespace:class:subclass|Subclass]] |
| Primary Indications | [[disease:page|Indication 1]]; [[disease:page|Indication 2]] |
| Route(s) | Oral / IV / SQ / INH |
| Onset |  |
| Duration |  |
| Metabolism | CYP ___ / none |
| Half-life |  |
| Elimination | Renal / Hepatic / Both |
| Pregnancy |  |
| Renal Adjustment | Yes / No |
| Hepatic Adjustment | Yes / No |
| Black Box Warning | Yes / No |
| Controlled | No / C-II / C-IV |
| FDA Approval | YYYY |
</WRAP>
</WRAP>

====== Generic (Brand®) ======

<span class="badge badge-common">Common</span>
<span class="badge badge-firstline">First-line</span>
<!-- Optional: <span class="badge badge-bbw">Black Box</span> -->
<!-- Optional: <span class="badge badge-qt">QT Risk</span> -->

===== Overview =====
One tight paragraph:
  * What the drug is
  * Where it fits clinically (first-line vs add-on)
  * The “why it matters” outcome or key role

===== Mechanism of Action =====
  * Primary target (receptor/enzyme/transporter):
  * Downstream signal/pathway:
  * Net physiologic effect (what variable changes):
  * Why that helps the disease state:

===== Indications =====
  * [[disease:page|Indication 1]]
  * [[disease:page|Indication 2]]
  * Common off-label:
    * [[disease:page|Off-label 1]]

<WRAP blackbox>
===== Black Box Warning =====
  * (If none, delete this entire blackbox section.)
</WRAP>

<WRAP contra>
===== Contraindications =====
Absolute:
  * 
Relative / Cautions:
  * 
</WRAP>

<WRAP details>
===== Dosing =====
Adult:
  * Starting dose:
  * Typical dose:
  * Max dose:
Titration:
  * 
Renal dosing:
  * 
Hepatic dosing:
  * 
Special populations:
  * Elderly:
  * Pregnancy:
</WRAP>

<WRAP details>
===== Pharmacokinetics =====
Absorption:
  * 
Bioavailability:
  * 
Protein binding:
  * 
Distribution:
  * 
Metabolism:
  * [[cyp:start|CYP pathways]] (if relevant)
Half-life:
  * 
Elimination:
  * Renal / Hepatic / Both
</WRAP>

<WRAP details>
===== Adverse Effects =====
Common:
  * 
Serious:
  * 
Mechanism-based:
  * 
</WRAP>

<WRAP details>
===== Drug Interactions =====
CYP:
  * Inhibitors:
  * Inducers:
Additive physiologic effects:
  * 
High-yield “do not miss”:
  * 
</WRAP>

<WRAP monitoring>
===== Monitoring =====
Vitals:
  * 
Labs:
  * 
ECG (if relevant):
  * 
Clinical response:
  * 
</WRAP>

<WRAP pearls>
===== Clinical Pearls =====
  * 
  * 
  * 
</WRAP>

===== Comparison Within Class =====
  * How it differs from others in [[namespace:class:start|Class Name]]:
    * potency / selectivity:
    * duration:
    * renal vs hepatic clearance:
    * outcome evidence:
    * “best use case” patient:

===== Related =====
  * [[namespace:class:start|Class: Class Name]]
  * [[module:start|Module Landing Page]]
  * [[endocrine:start|Endocrine Pharmacology]] (or [[cardio:intro:start|Cardiovascular Pharmacology]])